Sponge delivery variables and tissue levels of 5-fluorouracil

British Journal of Ophthalmology

Volumn 84, Issue 1, 2000, Pages 92-97

  Wilkins, Mark R ^a   Occleston, Nicholas L ^a   Kotecha, Aachal ^a,b   Waters, Lorraine ^a   Khaw, Peng T ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ANIMAL TISSUE; ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; INTRAOCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SCLERA; SPONGE; SWINE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIMETABOLITES; CARBON RADIOISOTOPES; CONJUNCTIVA; FLUOROURACIL; SCLERA; SURGICAL SPONGES; SWINE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0034101525     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.1.92     Document Type: Article

References (40)

1. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996;121:349-66.
2. Lamping KA, Belkin JK. 5-Fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995;102:70-5.
3. Gandolfi SA, Vecchi M. 5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial. Ophthalmology 1997;104:181-6.
4. Egbert PR, Williams AS, Singh K, et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 1993;116:612-6.
5. Costa VP, Wilson RP, Moster MR, et al. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg 1993;24:389-94.
6. Shields MB, Scroggs MW, Sloop CM, et al. Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 1993;116:673-83.
7. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 1993;116:314-26.
8. Caronia RM, Liebmann JM, Friedman R, et al. Trabeculectomy at the inferior limbus. Arch Ophthalmol 1996;114: 387-91.
9. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-9.
10. Higginbotham EJ, Stevens RK, Musch DC, et al. Blebrelated endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650-6.
11. Megevand GS, Salmon JF, Scholtz RP, et al. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995;102:84-90.
12. Wolner B, Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053-60.
13. Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997;115:969-74.
14. Shin DH, Simone PA, Song MS, et al. Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. Ophthalmology 1995;102:1550-8.
15. Shin DH, Hughes BA, Song MS, et al. Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure. Ophthalmology 1996;103:1925-33.
16. Kitazawa Y, Suemori Matsushita H, Yamamoto T, et al. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993;100:1624-8.
17. Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990;6:175-82.
18. Mietz H, Krieglstein GK. Short-term clinical results and complications of trabeculectomies performed with mitomycin C using different concentrations. Int Ophthalmol 1995;19:51-6.
19. Kawase K, Matsushita H, Yamamoto T, et al. Mitomycin concentration in rabbit and human ocular tissues after topical administration. Ophthalmology 1992;99:203-7.
20. Flynn WJ, Carlson DW, Biffano SL. Mitomycin trabeculectomy: the microsurgical difference. J. Glaucoma 1995;4:86-90.
21. Cordeiro MF, Constable PH, Alexander RA, et al. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1997;38:1639-46.
22. Shin DH, Reed SY, Swords RC, et al. Cellulose sponge punch for controlled mitomycin application. Arch Ophthalmol 1994;112:1624-5.
23. Chen PP, Yamamoto T, Sawada A, et al. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese glaucoma societies. J Glaucoma 1997;6:192-6.
24. Munden PM, Alward WL. Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. Am J Ophthalmol 1995;119: 20-9.
25. Madhavan HN, Rao SB, Vijaya L, et al. In vitro sensitivity of human Tenon's capsule fibroblasts to mitomycin C and its correlation with outcome of glaucoma filtration surgery. Ophthalmic Surg 1995;26:61-7.
26. Lederer CM Jr. Combined cataract extraction with intraocular lens implant and mitomycin-augmented trabeculectomy. Ophthalmology 1996;103:1025-34.
27. Costa VP, Moster MR, Wilson RP, S et al. Effects of topical mitomycin C on primary trabeculectomies and combined procedures. Br J Ophthalmol 1993;77:693-7.
28. Campagna JA, Munden PM, Alward WL. Tenon's cyst formation after trabeculectomy with mitomycin C. Ophthalmic Surg 1995;26:57-60.
29. Khaw PT, Doyle JW, Sherwood MB, et al. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993;111:263-7.
30. Khaw PT, Sherwood MB, Doyle JW, et al. Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-C: long term effects in vivo on subconjunctival and scleral fibroblasts. Int Ophthalmol 1992;16:381-5.
31. Cohen JS, Greff LJ, Novack GD, et al. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996; 103:1934-42.
32. Smith MF, Sherwood MB, Doyle JW, et al. Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol 1992;114: 737-41.
33. Mora JS, Nguyen N, Iwach AG, et al. Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology 1996; 103:963-70.
34. Dreyer EB, Chaturvedi N, Zurakowski D. Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. Arch Ophthalmol 1995;113:578-80.
35. Greenfield DS, Miller MP, Suner IJ, et al. Needle elevation of the scleral flap for failing nitration blebs after trabeculectomy with mitomycin C. Am J Ophthalmol 1996;122:195-204.
36. Joos KM, Bueche MJ, Palmberg PF, et al. One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. Ophthalmology 1995;102(1):76-83.
37. Kupin TH, Juzych MS, Shin DH, et al. Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 1995;119:30-9.
38. Lachkar Y, Leyland M, Bloom P, et al. Trabeculectomy with intraoperative sponge 5-FU in Afro-Caribbeans. Br J Ophthalmol 1997;81:555-8.
39. Costa VP, Comegno PE, Vasconcelos JP, et al. Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. J Glaucoma 1996;5:193-9.
40. Kitazawa Y, Kawase K, Matsushita H, et al. Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991;109:1693-8.